The UNITED consortium is excited to announce that the Study of health in Pomerania Study has joined the consortium. The Study of Health in Pomerania Study (SHIP) is a population-based study including two independent cohorts, SHIP and SHIP-TREND beggining in 1997 and...

  We are excited to announce that the UC Davis Alzheimer's Diversity Study has joined the UNITED consortium. The UC Davis Alzheimer's Diversity Study, based in Davis, USA, focuses on looking into diverse populations and investigating if a mixture of influences...

We are excited to announce that the Prospective Dementia Registry-Austria (PRODEM-Austria) has joined the UNITED consortium. PRODEM-Austria, financed by The Austrian Alzheimer Society, is an ongoing national prospective dementia registry including...

The GeneSTAR Study has joined the UNITED consortium. GeneStar is a family-based study in initially healthy brothers and sisters, and offspring of people with early-onset coronary disease (CHD). Based in  in Baltimore, USA, the study investigates mechanisms of CHD and...

It has been a week since the AAIC and we have had time to reflect on a wonderful week in the sun. The conference is an exciting international meeting drawing fascinating speakers and topics, together with attendees who are passionate about the cause. The conference as...

We are delighted to begin working with SURFSara through the approval of our NWO grant. Through this project we have been granted a dedicated UNITED project space to the Dutch national computer, Cartesius. This is a general purpose capability system which includes many...

We are happy to announce a new partner: Mikolaj Pawlak. Dr. Pawlak is a neurologist from Poznan University, and joins the UNITED consortium with much needed clinical data from underrepresented Eastern European populations. Welcome!

Publication of findings from the EU-funded Full-HD Working Group! Issues remain to fully leverage high-dimensional data, such as that these data are
difficult to harmonize. In this working group we focused on the harmonization of high-dimensional neuroimaging phenotypes in combination with other
high-dimensional omics data.
accessible in neurodegeneration research